Monday - June 22, 2026
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
January 12, 2026
SANTA CLARA, California, Jan. 12 [Category: BizComputer Technology] -- NVIDIA, a designer of graphics processing units for the gaming, cryptocurrency and professional markets, issued the following news release:

* * *

NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery

*

News Summary:

* Lilly and NVIDIA launch AI co-innovation lab to tackle drug discovery challenges.

* NVI . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products